PET/MRI scan with a small injected tracer
Part of Brain & nervous system clinical trials.
This study tests a new brain PET “insert” that can work at the same time as MRI to create brain images. If you’re healthy and can receive an approved injected tracer (FDG or Neuraceq), you may be able to help confirm the device works safely and clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’ve had less than 5,000 mrem of radiation in the past year
- You are at least 21 years old
- You can and agree to have a tracer injected (6–12 mCi of FDG or Neuraceq)
- You can sign written consent after understanding the study
- You have no known allergy to the injected imaging tracer
- You do not have metal implants that would be unsafe for MRI
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special PET/MR imaging scan to look at how the brain works in people with certain brain disorders. The scan might help doctors understand the condition better and improve treatment.
This study tests a new way to take brain imaging scans (PET scans) using a very small amount of radioactive tracer. Researchers want to see if they can get clear pictures of your brain while reducing your radiation exposure compared to standard scans.
This Phase 1 study tests a special tracer used during MRI and PET scans to look at brain changes in people with multiple sclerosis. It’s mainly aimed at improving how these scans can detect disease-related changes and confirming the tracer works safely.
This study uses a special type of MRI scan combined with PET imaging to look at brain tumors after treatment. It aims to figure out whether new spots seen on MRI are leftover tumor or treatment effects, which could help guide your next care steps.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This study uses a new radioactive tracer called [18F]-FZTA during a PET scan to see inflammation in the brain. Researchers want to test this tracer in both healthy adults and people with multiple sclerosis (MS) to see if it can help detect MS activity.
Hear when a new Brain Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.